[
    [
        {
            "time": "",
            "original_text": "直追药明康德，泰格一天豪掷9亿投向新医药，康龙化成、凯莱英一众CXO扎堆进入",
            "features": {
                "keywords": [
                    "药明康德",
                    "泰格",
                    "新医药",
                    "康龙化成",
                    "凯莱英",
                    "CXO"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "直追药明康德，泰格一天豪掷9亿投向新医药，康龙化成、凯莱英一众CXO扎堆进入",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "仿制药板块震荡回落，丽珠集团跌超2%、泰格医药翻绿",
            "features": {
                "keywords": [
                    "仿制药",
                    "丽珠集团",
                    "泰格医药"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "仿制药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "仿制药板块震荡回落，丽珠集团跌超2%、泰格医药翻绿",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "CXO泡沫浴：分享创新药红利的最好方式",
            "features": {
                "keywords": [
                    "CXO",
                    "创新药",
                    "泡沫"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "CXO泡沫浴：分享创新药红利的最好方式",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]